Civil Court Rules and Jury Charges

Kenneth Vercammen & Associates, P.C.
2053 Woodbridge Avenue - Edison, NJ 08817

Tuesday, June 21, 2011

Revised CIVIL CASE INFORMATION STATEMENT (CIVIL CIS)

Revised CIVIL CASE INFORMATION STATEMENT (CIVIL CIS)
NOTICE TO THE BAR


REVISIONS TO SIDE 2 REGARDING TRACK IV CASE TYPES

The Civil Case Information Statement (“Civil CIS”) is included in the Rules of Court as Appendix XII-B1. The Supreme Court previously delegated to the Administrative Director the authority to approve revisions to Side 2 of the Civil CIS. This Notice is to advise the bar of the approval of several such revisions to Side 2. The complete Civil CIS as revised is attached. No changes have been made to Side 1. The approved revisions, which are effective June 20, 2011, are as follows:

the addition of case type 293 for the DePuy ASR Hip Implant litigation, pursuant to the Supreme Court’s April 12, 2011 Order centralizing the management of the litigation but not designating it as a mass tort;

the addition of the term “Isotretinoin” to the description of case type 271, pursuant to the Supreme Court’s May 4, 2011 Order designating litigation involving Isotretinoin (generic Accutane) as part of the Accutane Litigation mass tort designation;

the removal of case type 275 for the Ortho Evra Birth Control Patch litigation, pursuant to the Supreme Court’s March 8, 2011 Order terminating mass tort designation and centralized management of the litigation;

the removal of case type 277 for the Mahwah Toxic Dump Site litigation, pursuant to the Supreme Court’s May 4, 2011 Order terminating mass tort designation and centralized management of the litigation; and

the removal of case type 283 for the Digitek litigation, pursuant to the Supreme Court’s May 17, 2011 Order terminating mass tort designation and centralized management of the litigation.

Appendix XII-B1

FOR USE BY CLERK’S OFFICE ONLY

Effective 06/20/2011, CN 10517-English page 1 of 2

PAYMENT TYPE: CK CG CA

CHG/CK NO.

AMOUNT:

OVERPAYMENT:

BATCH NUMBER:

CIVIL CASE INFORMATION STATEMENT

(CIS)

Use for initial Law Division

Civil Part pleadings (not motions) under Rule 4:5-1

Pleading will be rejected for filing, under Rule 1:5-6(c),

if information above the black bar is not completed

or attorney’s signature is not affixed

ATTORNEY / PRO SE NAME TELEPHONE NUMBER COUNTY OF VENUE

FIRM NAME (if applicable) DOCKET NUMBER (when available)

OFFICE ADDRESS DOCUMENT TYPE

JURY DEMAND YES NO

NAME OF PARTY (e.g., John Doe, Plaintiff) CAPTION

CASE TYPE NUMBER (See reverse side for listing) IS THIS A PROFESSIONAL MALPRACTICE CASE? YES NO

IF YOU HAVE CHECKED “YES,” SEE N.J.S.A. 2A:53 A -27 AND APPLICABLE CASE LAW

REGARDING YOUR OBLIGATION TO FILE AN AFFIDAVIT OF MERIT.

RELATED CASES PENDING? IF YES, LIST DOCKET NUMBERS

YES NO

DO YOU ANTICIPATE ADDING ANY PARTIES NAME OF DEFENDANT’S PRIMARY INSURANCE COMPANY (if known)

(arising out of same transaction or occurrence)? NONE

YES NO

UNKNOWN

THE INFORMATION PROVIDED ON THIS FORM CANNOT BE INTRODUCED INTO EVIDENCE.

CASE CHARACTERISTICS FOR PURPOSES OF DETERMINING IF CASE IS APPROPRIATE FOR MEDIATION

DO PARTIES HAVE A CURRENT, PAST OR IF YES, IS THAT RELATIONSHIP:

RECURRENT RELATIONSHIP? EMPLOYER/EMPLOYEE FRIEND/NEIGHBOR OTHER (explain)

YES NO FAMILIAL BUSINESS

DOES THE STATUTE GOVERNING THIS CASE PROVIDE FOR PAYMENT OF FEES BY THE LOSING PARTY? YES NO

USE THIS SPACE TO ALERT THE COURT TO ANY SPECIAL CASE CHARACTERISTICS THAT MAY WARRANT INDIVIDUAL MANAGEMENT OR

ACCELERATED DISPOSITION

DO YOU OR YOUR CLIENT NEED ANY DISABILITY ACCOMMODATIONS? IF YES, PLEASE IDENTIFY THE REQUESTED ACCOMMODATION

YES NO

WILL AN INTERPRETER BE NEEDED? IF YES, FOR WHAT LANGUAGE?

YES NO

I certify that confidential personal identifiers have been redacted from documents now submitted to the court, and will be

redacted from all documents submitted in the future in accordance with Rule 1:38-7(b).

ATTORNEY SIGNATURE:

Side 2

CIVIL CASE INFORMATION STATEMENT

(CIS)

Use for initial pleadings (not motions) under Rule 4:5-1

CASE TYPES (Choose one and enter number of case type in appropriate space on the reverse side.)

Track I - 150 days' discovery

151 NAME CHANGE

175 FORFEITURE

302 TENANCY

399 REAL PROPERTY (other than Tenancy, Contract, Condemnation, Complex Commercial or Construction)

502 BOOK ACCOUNT (debt collection matters only)

505 OTHER INSURANCE CLAIM (including declaratory judgment actions)

506 PIP COVERAGE

510 UM or UIM CLAIM (coverage issues only)

511 ACTION ON NEGOTIABLE INSTRUMENT

512 LEMON LAW

801 SUMMARY ACTION

802 OPEN PUBLIC RECORDS ACT (summary action)

999 OTHER (briefly describe nature of action)

Track II - 300 days' discovery

305 CONSTRUCTION

509 EMPLOYMENT (other than CEPA or LAD)

599 CONTRACT/COMMERCIAL TRANSACTION

603N AUTO NEGLIGENCE – PERSONAL INJURY (non-verbal threshold)

603Y AUTO NEGLIGENCE – PERSONAL INJURY (verbal threshold)

605 PERSONAL INJURY

610 AUTO NEGLIGENCE – PROPERTY DAMAGE

621 UM or UIM CLAIM (includes bodily injury)

699 TORT – OTHER

Track III - 450 days' discovery

005 CIVIL RIGHTS

301 CONDEMNATION

602 ASSAULT AND BATTERY

604 MEDICAL MALPRACTICE

606 PRODUCT LIABILITY

607 PROFESSIONAL MALPRACTICE

608 TOXIC TORT

609 DEFAMATION

616 WHISTLEBLOWER / CONSCIENTIOUS EMPLOYEE PROTECTION ACT (CEPA) CASES

617 INVERSE CONDEMNATION

618 LAW AGAINST DISCRIMINATION (LAD) CASES

Track IV - Active Case Management by Individual Judge / 450 days' discovery

156 ENVIRONMENTAL/ENVIRONMENTAL COVERAGE LITIGATION

303 MT. LAUREL

508 COMPLEX COMMERCIAL

513 COMPLEX CONSTRUCTION

514 INSURANCE FRAUD

620 FALSE CLAIMS ACT

701 ACTIONS IN LIEU OF PREROGATIVE WRITS

Centrally Managed Litigation (Track IV)

280 ZELNORM

290 POMPTON LAKES ENVIRONMENTAL LITIGATION

285 STRYKER TRIDENT HIP IMPLANTS

291 PELVIC MESH/GYNECARE

288 PRUDENTIAL TORT LITIGATION

292 PELVIC MESH/BARD

289 REGLAN

293 DEPUY ASR HIP IMPLANT LITIGATION

Mass Tort (Track IV)

248 CIBA GEIGY

281 BRISTOL-MYERS SQUIBB ENVIRONMENTAL

266 HORMONE REPLACEMENT THERAPY (HRT)

282 FOSAMAX

271 ACCUTANE/ISOTRETINOIN

284 NUVARING

274 RISPERDAL/SEROQUEL/ZYPREXA

286 LEVAQUIN

278 ZOMETA/AREDIA

287 YAZ/YASMIN/OCELLA

279 GADOLINIUM

601 ASBESTOS

If you believe this case requires a track other than that provided above, please indicate the reason on Side 1, in the space under "Case Characteristics.

Please check off each applicable category

Putative Class Action

Title 59

Effective 06/20/2011, CN 10517-English page 2 of 2